Pharmacological Drug Response Monitoring via PPG: Cardiovascular Effects, Anesthesia & Therapeutic Drug Monitoring
**Every pharmacological agent that affects heart rate, vascular tone, cardiac contractility, or autonomic function produces measurable changes in the ...
- Heart Rate
Every pharmacological agent that affects heart rate, vascular tone, cardiac contractility, or autonomic function produces measurable changes in the photoplethysmographic waveform, making PPG a uniquely positioned technology for continuous, non-invasive drug response monitoring. From titrating vasopressors in the ICU to tracking beta-blocker efficacy in outpatient cardiology, PPG-derived parameters provide real-time pharmacodynamic feedback that complements conventional monitoring modalities.
This article reviews the scientific evidence for PPG-based drug response monitoring across major pharmacological classes, including cardiovascular agents, anesthetic drugs, and analgesics. We cover the physiological mechanisms linking drug action to PPG waveform changes, the specific PPG features used for monitoring, and the clinical validation evidence. For foundational PPG concepts, see our introduction to PPG technology. For details on signal processing methods, visit our algorithms overview.
Physiological Basis of Drug-Induced PPG Changes
The PPG signal reflects the dynamic interaction between cardiac pump function, arterial wave propagation, and microvascular perfusion. Pharmacological agents modulate these components through multiple mechanisms, each producing distinct and often predictable PPG waveform changes.
Cardiac Effects
Drugs that alter heart rate produce the most obvious PPG changes: shorter inter-beat intervals with chronotropic agents and longer intervals with negative chronotropes. Beyond rate, inotropic agents change the systolic upstroke slope (dP/dt) and peak amplitude. Positive inotropes (dobutamine, milrinone) increase systolic peak amplitude and steepen the upstroke, while negative inotropes reduce both parameters. These changes are mediated through altered left ventricular stroke volume and ejection velocity.
Lusotropic agents that affect myocardial relaxation alter the diastolic phase of the PPG waveform. Improved diastolic function produces earlier and more prominent diastolic wave components, while impaired relaxation compresses the diastolic interval and attenuates the dicrotic notch.
Vascular Effects
Vasodilators and vasoconstrictors profoundly affect PPG morphology through their action on arterial tone and peripheral resistance. Vasodilation reduces the augmentation index (AIx) by decreasing wave reflection magnitude, increases pulse amplitude through improved microvascular perfusion, and alters the timing of the dicrotic notch. Vasoconstriction produces the opposite effects: increased AIx, reduced pulse amplitude, and a more prominent reflected wave component.
The second derivative of the PPG (SDPPG) is particularly sensitive to vascular drug effects. Takazawa et al. (1998) recorded ascending aortic pressure alongside the fingertip SDPPG in 39 patients: the d/a ratio decreased after angiotensin (from -0.40 to -0.62) and increased after 0.3 mg sublingual nitroglycerin (to -0.25), tracking the drug-induced changes in central pressure (doi:10.1161/01.HYP.32.2.365).
Autonomic Effects
Drugs with autonomic nervous system effects (sympathomimetics, parasympathomimetics, anticholinergics) alter the heart rate variability patterns extractable from PPG. Atropine, for example, eliminates high-frequency (vagal) HRV components while preserving low-frequency (sympathetic) components, producing a characteristic increase in the LF/HF ratio. Propranolol reduces both LF power and heart rate while increasing HRV regularity. These autonomic signatures in the PPG provide a non-invasive window into the balance between sympathetic and parasympathetic drug effects.
Cardiovascular Drug Classes
Beta-Adrenergic Blockers
Beta-blockers are among the most prescribed cardiovascular medications, and their effects are readily monitored via PPG. The primary PPG changes include heart rate reduction (negative chronotropy), decreased pulse amplitude variability, altered HRV spectral profile (reduced LF/HF ratio), and increased pulse wave transit time.
Longitudinal monitoring of beta-blocker response using wearable PPG devices has also been proposed for adherence monitoring, since missed doses can produce a rebound increase in resting heart rate and HRV changes.
Calcium Channel Blockers
Calcium channel blockers (CCBs) produce distinct PPG changes depending on their subclass. Dihydropyridine CCBs (amlodipine, nifedipine) primarily cause arterial vasodilation, producing increased PPG pulse amplitude, reduced augmentation index, and reflex tachycardia. Non-dihydropyridine CCBs (verapamil, diltiazem) additionally reduce heart rate and contractility.
The perfusion index (PI), defined as the ratio of pulsatile to non-pulsatile PPG signal components, rises with peripheral vasodilation and is therefore a candidate bedside indicator of drug-induced vasodilation.
Nitrates and Nitric Oxide Donors
Nitroglycerin and other nitric oxide donors produce rapid, dose-dependent PPG changes that serve as a model for PPG-based pharmacodynamic monitoring. The primary effects include reduced augmentation index (reflecting decreased wave reflection), decreased pulse wave velocity (reflecting reduced arterial stiffness), increased pulse amplitude (reflecting improved microvascular perfusion), and altered SDPPG waveform ratios.
Because these waveform changes can be tracked continuously, PPG monitoring could be useful for nitroglycerin dose titration in acute coronary syndromes and heart failure. Continuous PPG monitoring could enable more precise titration than intermittent cuff measurements, potentially reducing the risk of hypotensive episodes during nitroglycerin therapy.
Vasopressors and Inotropes
In the critical care setting, PPG monitoring provides continuous hemodynamic feedback during vasopressor and inotrope titration. Each agent class produces a characteristic PPG signature:
Norepinephrine (alpha-1 predominant at moderate doses) reduces PPG pulse amplitude through vasoconstriction, increases augmentation index, and raises perfusion index through improved mean arterial pressure and cardiac output. Paradoxically, severe vasoconstriction can reduce the PPG signal to the point of unreliability, which is itself clinically informative.
Dopamine produces dose-dependent PPG changes: at low doses (2-5 mcg/kg/min, dopaminergic receptor activation), renal and splanchnic vasodilation increases finger PPG amplitude; at moderate doses (5-10 mcg/kg/min, beta-1 activation), heart rate and contractility increase; at high doses (>10 mcg/kg/min, alpha-1 activation), peripheral vasoconstriction reduces pulse amplitude.
Dobutamine (beta-1 predominant) increases PPG pulse amplitude through enhanced contractility and stroke volume, with a mild decrease in augmentation index due to peripheral beta-2 vasodilation.
Anesthesia Monitoring
Depth of Anesthesia Assessment
PPG-derived parameters have been investigated as indicators of anesthetic depth, complementing electroencephalography-based indices such as the Bispectral Index (BIS). The rationale is that anesthetic agents produce dose-dependent cardiovascular depression that is reflected in PPG features.
The Surgical Pleth Index (SPI), also known as the Surgical Stress Index (SSI), is a commercially available PPG-derived parameter (GE Healthcare) calculated from the normalized pulse beat interval and PPG pulse wave amplitude. SPI ranges from 0 to 100, with higher values indicating greater nociceptive stimulation. Huiku et al. (2007) introduced the index (then called SSI) as 100 - (0.7 x normalized pulse wave amplitude + 0.3 x normalized heart beat interval) and showed that it increased at skin incision and responded to remifentanil concentration changes during propofol-remifentanil anaesthesia (doi:10.1093/bja/aem004).
Randomized studies of SPI-guided analgesia have reported lower opioid use. In 80 ENT surgery patients, Chen et al. (2010) found lower remifentanil consumption with SSI guidance (9.5 vs. 12.3 mcg/kg/h), more stable hemodynamics, and fewer unwanted events (doi:10.1097/ALN.0b013e3181d3d641). In 170 outpatients, Bergmann et al. (2013) found that SPI-guided remifentanil dosing reduced both remifentanil and propofol consumption and shortened recovery times (doi:10.1093/bja/aes426). Because SPI is built from pulse amplitude and heart rate, vasoactive drugs and other factors that change these signals can also affect it.
Pleth Variability Index and Fluid Responsiveness
The Pleth Variability Index (PVI), developed by Masimo, quantifies respiratory-induced variations in the PPG pulse amplitude. PVI reflects the cyclic changes in intrathoracic pressure during mechanical ventilation and their effect on venous return and stroke volume. Higher PVI values indicate greater fluid responsiveness, defined as a significant increase in cardiac output following fluid administration.
Cannesson et al. (2008) studied 25 mechanically ventilated patients under general anaesthesia and found that a PVI > 14% before volume expansion (500 mL hetastarch 6%) discriminated fluid responders (cardiac index increase of at least 15%) from non-responders with 81% sensitivity and 100% specificity (doi:10.1093/bja/aen133). Performance is generally expected to be lower in patients with spontaneous breathing, arrhythmias, or open-chest conditions.
Forget et al. (2010) randomized 82 patients undergoing major abdominal surgery to PVI-directed fluid management or standard care. The PVI group received less intraoperative crystalloid and less total fluid, and had lower lactate levels during surgery and 48 hours afterwards (doi:10.1213/ANE.0b013e3181eb624f).
Perfusion Index in Regional Anesthesia
The PPG perfusion index (PI) has emerged as a rapid, non-invasive indicator of successful regional anesthesia. Sympathetic block from epidural or peripheral nerve block produces vasodilation in the blocked dermatomes, resulting in increased PI in the affected limb.
Ginosar et al. (2009) studied lumbar epidural anesthesia: in 29 patients with analyzable PPG signals, toe PI rose by 326% by 20 minutes, while MAP fell 10% and toe temperature rose 3%. A 100% PI increase identified sympathectomy in 15/29, 26/29, and 29/29 patients at 5, 10, and 20 minutes, earlier and more often than MAP or temperature criteria (doi:10.1111/j.1399-6576.2009.01968.x).
This application of PPG is particularly valuable in pediatric and obstetric anesthesia where patient cooperation for traditional sensory testing may be limited. The objectivity and rapidity of PI-based block assessment reduces the time to surgical readiness and helps identify failed blocks before surgical incision.
Analgesic and Sedative Monitoring
Opioid Response Assessment
Opioid administration produces characteristic PPG changes including bradycardia (through vagal stimulation), decreased respiratory rate (detectable from PPG respiratory-induced variations), reduced pulse amplitude variability, and altered HRV patterns. The magnitude of these changes correlates with plasma opioid concentration and analgesic effect, though inter-individual variability is substantial.
PPG-derived respiratory rate has therefore been proposed as a monitor for opioid-induced respiratory depression. The ability to detect opioid-induced respiratory depression through continuous PPG monitoring has important implications for patient safety, particularly on general hospital wards where continuous capnography or pulse oximetry may not be routinely applied. Wearable PPG devices could provide continuous respiratory monitoring for postoperative patients during the critical first 24-48 hours after surgery.
Sedation Depth Monitoring
PPG-derived parameters have been explored for sedation depth assessment during procedural sedation and in the ICU. Heart rate variability analysis shows characteristic changes with deepening sedation: decreased total HRV power, reduced high-frequency (vagal) component, and loss of the physiological LF/HF circadian variation.
PPG-based approaches are less established than EEG-based methods for this purpose, but they have the advantage of using pulse oximetry hardware already present in every monitored bed.
Pharmacokinetic-Pharmacodynamic Modeling with PPG
An emerging research direction is the integration of PPG-derived pharmacodynamic endpoints into population pharmacokinetic-pharmacodynamic (PK-PD) models. Traditionally, PK-PD modeling for cardiovascular drugs requires invasive hemodynamic measurements (arterial line blood pressure, thermodilution cardiac output) or intermittent non-invasive measurements (cuff blood pressure, echocardiography). PPG offers continuous pharmacodynamic data at a fraction of the cost and invasiveness.
Charlton et al. (2019) used a computational model to simulate pressure, flow, and PPG pulse waves for 4,374 virtual subjects with known cardiovascular properties, verifying the simulated waves against in vivo data (doi:10.1152/ajpheart.00218.2019). Such a forward model provides a theoretical framework for inverting the PPG signal to estimate pharmacodynamic effects, though the ill-posed nature of the inverse problem limits accuracy without additional constraints or measurements.
Future applications may include real-time dose optimization algorithms that use continuous PPG feedback to titrate vasoactive drugs to target hemodynamic endpoints, closed-loop analgesia systems that adjust opioid infusion rates based on PPG-derived nociception indices, and medication adherence monitoring using home PPG devices that detect the expected cardiovascular effects of prescribed medications.
Limitations and Research Gaps
Several limitations must be acknowledged when considering PPG for drug response monitoring:
Inter-individual variability. The same drug dose produces different PPG responses across individuals due to differences in baseline vascular tone, autonomic function, body composition, and genetic polymorphisms affecting drug metabolism. Population-level correlations between drug dose and PPG response are informative, but individual-level prediction requires personalized baseline calibration.
Confounding factors. Temperature, hydration, posture, emotional state, and concurrent medications all affect PPG parameters independently of the drug being monitored. In the ICU setting, where patients may be receiving 5-10 concurrent medications, isolating the PPG effect of a single agent is particularly challenging. Robust signal processing and motion artifact removal are essential prerequisites.
Regulatory and clinical workflow integration. PPG-derived pharmacodynamic parameters are not yet integrated into standard clinical decision support systems for most drug classes. The SPI and PVI represent exceptions in the anesthesia domain, but broader adoption requires prospective outcome studies demonstrating clinical benefit.
Conclusion
PPG provides a rich, continuously available window into the cardiovascular effects of pharmacological agents. The technology is already embedded in clinical practice through pulse oximetry, and advanced PPG analysis extends its utility to drug response monitoring, anesthesia assessment, and fluid management. The evidence base is strongest for vasodilator response tracking (AIx, SDPPG ratios), fluid responsiveness prediction (PVI), nociception assessment (SPI), and regional anesthesia confirmation (PI).
For researchers and engineers developing PPG-based drug monitoring applications, the key challenge is moving from group-level pharmacodynamic correlations to individual-level prediction models that account for inter-individual variability and confounding factors. Integration with population PK-PD models and closed-loop drug delivery systems represents the most impactful translational pathway. For more on PPG signal analysis methods, explore our algorithms documentation and our guide to PPG-detectable health conditions.
References
- Takazawa, K., et al. (1998). Assessment of vasoactive agents and vascular aging by the second derivative of photoplethysmogram waveform. Hypertension, 32(2), 365-370. https://doi.org/10.1161/01.HYP.32.2.365
- Huiku, M., et al. (2007). Assessment of surgical stress during general anaesthesia. British Journal of Anaesthesia, 98(4), 447-455. https://doi.org/10.1093/bja/aem004
- Chen, X., et al. (2010). Comparison of surgical stress index-guided analgesia with standard clinical practice during routine general anesthesia: a pilot study. Anesthesiology, 112(5), 1175-1183. https://doi.org/10.1097/ALN.0b013e3181d3d641
- Bergmann, I., et al. (2013). Surgical pleth index-guided remifentanil administration reduces remifentanil and propofol consumption and shortens recovery times in outpatient anaesthesia. British Journal of Anaesthesia, 110(4), 622-628. https://doi.org/10.1093/bja/aes426
- Cannesson, M., et al. (2008). Pleth variability index to monitor the respiratory variations in the pulse oximeter plethysmographic waveform amplitude and predict fluid responsiveness in the operating theatre. British Journal of Anaesthesia, 101(2), 200-206. https://doi.org/10.1093/bja/aen133
- Forget, P., Lois, F., & de Kock, M. (2010). Goal-directed fluid management based on the pulse oximeter-derived pleth variability index reduces lactate levels and improves fluid management. Anesthesia & Analgesia, 111(4), 910-914. https://doi.org/10.1213/ANE.0b013e3181eb624f
- Ginosar, Y., et al. (2009). Pulse oximeter perfusion index as an early indicator of sympathectomy after epidural anesthesia. Acta Anaesthesiologica Scandinavica, 53(8), 1018-1026. https://doi.org/10.1111/j.1399-6576.2009.01968.x
- Charlton, P. H., et al. (2019). Modeling arterial pulse waves in healthy aging: a database for in silico evaluation of hemodynamics and pulse wave indexes. American Journal of Physiology-Heart and Circulatory Physiology, 317(5), H1062-H1085. https://doi.org/10.1152/ajpheart.00218.2019
Related articles
PPG Pulse Pressure Variation Noninvasive Monitoring: Can Pleth Variability Guide Fluid Response?
PPG pulse pressure variation monitoring estimates respiratory-linked hemodynamic variability noninvasively, but its value depends on ventilation, rhythm, and signal quality.
PPG in Space Medicine: Cardiovascular Monitoring in Microgravity
Spaceflight produces profound cardiovascular changes including cephalad fluid shifts, plasma volume reduction, cardiac atrophy, and orthostatic intole...
PPG for Anesthesia Depth Monitoring: Surgical Applications of Photoplethysmography
**The pulse oximeter probe already attached to every surgical patient's finger contains far more information than the SpO2 and heart rate values displ...
Remote Patient Stress Monitoring: PPG Wearables in Telehealth
Guide to PPG-based remote patient stress monitoring covering clinical workflows, wearable device selection, data integration with telehealth platforms, and evidence for outcomes improvement.
PPG Diabetes Cardiovascular Risk
Type 2 diabetes mellitus carries a two-to-four times higher cardiovascular risk than the general population, driven largely by accelerated vascular ag...